Summary

Eligibility
for people ages 40 years and up (full criteria)
Location
at UCLA
Dates
study started
estimated completion

Description

Summary

Correlate performance of LungLB Test with outcome of a scheduled biopsy.

Official Title

Clinical Evaluation of LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

Keywords

Solitary Pulmonary Nodule, Multiple Pulmonary Nodules, Lung Cancer, Circulating Genetically Abnormal Cells (CGAC), 4-color FISH, Increased/Decreased Risk, Early Lung Cancer Detection, Indeterminate Nodule, Indeterminate Lung Nodule

Eligibility

You can join if…

Open to people ages 40 years and up

  1. At least 18 years old with a CT identified indeterminate pulmonary nodule and scheduled for biopsy, at the time of consent.
  2. Planned biopsy nodule of interest:
    1. is solid ≤3 cm; or
    2. is nonsolid, ground glass opacity, of any size; or
    3. is part solid, where the solid component is no larger than 3cm (maximum diameter).

You CAN'T join if...

  1. Current and or prior diagnosis +/- treatment of non-lung cancer within the past 3 years.
  2. Current and or prior lung cancer diagnosis within 2 years following intent-to-cure surgery.

Locations

  • Clinical Site 04 accepting new patients
    Los Angeles California 90095 United States
  • Clinical Site 18 currently not accepting new patients, but might later
    Reno Nevada 89502 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
LungLife AI
ID
NCT05171491
Study Type
Observational
Participants
Expecting 425 study participants
Last Updated